Wantstats
Company ProfilePremium

VITROLIFE

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
VITROLIFE - Healthcare showcase

Year Founded & Workforce

1994

400 Employees

Industry

Healthcare

Services

Oocyte Retrieval NeedlesSperm ProcessingIVF Media and OilMicromanipulation PipettesTime-Lapse System
V

VITROLIFE Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

VITROLIFE Overview

Company Headquarters: Sweden

Founded: 1994

Workforce: ~400

Company Working: Vitrolife is renowned as one of the leading providers of IVF laboratories with high-quality products. It offers a broad range of products for the preparation, cultivation, and storage of human cells, tissues, and organs which include needles, pipettes, incubators, and laser & imaging systems, among others. It operates through four business units including media, time-lapse, disposable devices, and art equipment. It runs production facilities in over ten countries worldwide.

Strategy

Vitrolife focuses on following sustainable business practices, strengthening sales support, and building a competitive product portfolio & efficient supply chain. It also emphasizes continuous monitoring of the external environment to grab new opportunities and investments in R&D activities to develop advanced solutions.

Company Snapshot

$100M

Revenue

400

Employees

1994

Founded

Sweden

Headquarters

SWOT Analysis

Strengths

  • Renowned player in the IVF market
  • Diverse product portfolio
  • Robust R&D

Opportunities

  • Expand business operations worldwide
  • Strategic initiatives such as partnerships and collaborations

Threats

  • Technological advancements by established players

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
August 2019Collaboration/AgreementVitrolife collaborated with Prime Tech Corporation, Japan, to develop and promote the Piezo technique for improved intracytoplasmic sperm injection (ICSI) procedure in human IVF worldwide except Japan, Thailand, and Malaysia.
May 2019AcquisitionVitrolife acquired Parallabs Ltd, a UK- and Ireland-based distributor of EmbryoScope time-lapse systems, to enhance its presence in the UK and Ireland.
April 2019AgreementVitrolife signed a transfer and collaboration agreement with Virtus Health, Australia, a technology company specializing in the development of artificial intelligence (AI) software in healthcare applications based in Australia for assessing embryos based on time-lapse video using AI.
June 2016Product DevelopmentVitrolife developed a new high-quality time-lapse system for disturbed culture and improved the selection of embryos under the brand name EmbryoScope+.

Product Offering

  • VITROLIFE
    • Oocyte Retrieval Needles
    • Sperm Processing
    • IVF Media and Oil
    • Micromanipulation Pipettes
    • Time-Lapse System
    • Cryopreservation
    • Laser & Imaging Systems

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: sales rose from USD 100 Mn in 2016 to USD 133 Mn in 2018.
VITROLIFE — By Business Segment
Series (USD Mn)201620172018
sales100123133

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →